Chinese scientists use knowledge from climate system modeling to develop a global prediction system for the COVID-19 pandemic

Newswise — At the time of writing, coronavirus disease 2019 (COVID-19) is seriously threatening human lives and health throughout the world. Before effective vaccines and specific drugs are developed, non-pharmacological interventions and numerical model predictions are essential. To this end, a group led by Professor Jianping Huang from Lanzhou University, China, developed the Global Prediction System of the COVID-19 Pandemic (GPCP).

Jianping Huang is a Professor in the College of Atmospheric Sciences and a Director of the Collaborative Innovation Center for Western Ecological Safety, Lanzhou University, China. He has for a long time been dedicated to studying long-term climate prediction, dust-cloud interaction, and semi-arid climate change by combining field observations and theoretical research. Lockdown in early 2020 seriously affected his research. Therefore, stuck at home, he held online discussions with his team members on how their experience of developing climate system models might be able to contribute to fighting the pandemic. He didn't expect much response, but was surprised and touched when many of his colleagues responded enthusiastically.

Therefore, he and his team combined the results of 30 years of work in statistical dynamic numerical weather prediction methods, and developed the GPCP based on the traditional Susceptible-Infected-Recovered (SIR) infectious disease model. The improved methods and results were published in Atmospheric and Ocean Science Letters.

In order to combine epidemiological data and models, the Levenberg-Marquardt (LM) parameter optimization algorithm was proposed to identify epidemiological models, thereby constructing a Statistical-SIR model. The LM algorithm introduces a damping coefficient when calculating the Hessian matrix by the traditional least-squares method, thereby combining the advantage of the Gauss-Newton method and gradient descent method and improving the stability of parameters.

"From the simulation results of four selected countries with relatively high numbers of confirmed cases, the Statistical-Susceptible-Infected-Recovered model using the LM algorithm was found to be more consistent with the actual curve of the epidemic, being better able to reflect its trend of development," explains Prof. Huang.

In addition, the ensemble empirical mode decomposition (EEMD) model and the autoregressive moving average (ARMA) model were also used in combination to improve the prediction results of the GPCP. The EEMD method has been widely used in the fields of engineering, meteorology, ecology, etc. It can decompose the signal according to its own scale, and is suitable for non-stationary and nonlinear signal processing. The ARMA method can better predict time series.

"We found that the EEMD-ARMA method can be directly used to predict the number of daily new cases in countries with a smaller number of confirmed cases whose development trend cannot be predicted by the infectious disease model. Based on the results, this method is more effective for improving prediction results and making direct predictions," concludes Prof. Huang.

The GPCP model developed by Jianping Huang's team can carry out targeted predictions for different countries and regions, and has achieved good prediction results. The team will continue to improve the model in the future to provide more accurate forecasts for different countries and regions.

###

SEE ORIGINAL STUDY




Filters close

Showing results

110 of 5429
Released: 16-Apr-2021 4:10 PM EDT
Rutgers Expert Addresses Questions on COVID-19 Vaccine Rollout and Variant Issues
Rutgers University-New Brunswick

Stanley H. Weiss, an epidemiologist in infectious and chronic diseases, and a professor at the Rutgers New Jersey Medical School and the Rutgers School of Public Health, talks about vaccine side effects, the hesitancy that still exists and why it is important to get vaccinated when it’s your turn.

Released: 16-Apr-2021 3:15 PM EDT
Studies suggest people with blood cancers may not be optimally protected after COVID-19 vaccination
American Society of Hematology (ASH)

Two new studies published in Blood suggest that the mRNA COVID-19 vaccine may have reduced efficacy in individuals with chronic lymphocytic leukemia (CLL) and multiple myeloma, two types of blood cancer.

Newswise: Simulations reveal how dominant SARS-CoV-2 strain binds to host, succumbs to antibodies
Released: 16-Apr-2021 2:35 PM EDT
Simulations reveal how dominant SARS-CoV-2 strain binds to host, succumbs to antibodies
Los Alamos National Laboratory

Large-scale supercomputer simulations at the atomic level show that the dominant G form variant of the COVID-19-causing virus is more infectious partly because of its greater ability to readily bind to its target host receptor in the body, compared to other variants.

Newswise: 262279_web.jpg
Released: 16-Apr-2021 2:15 PM EDT
Experimental antiviral for COVID-19 effective in hamster study
NIH, National Institute of Allergy and Infectious Diseases (NIAID)

The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study from National Institutes of Health scientists.

Newswise:Video Embedded forum-tackles-vaccine-hesitancy-in-the-black-community
VIDEO
Released: 16-Apr-2021 1:25 PM EDT
Forum Tackles Vaccine Hesitancy in the Black Community
Cedars-Sinai

Leading healthcare and faith leaders addressed key issues that are contributing to vaccine hesitancy in Black communities during a national online discussion this week, explaining that a lack of access to healthcare, concerns over vaccine safety, and religious beliefs are keeping many from getting COVID-19 vaccines.

Newswise: COVID-19: Scientists identify human genes that fight infection
Released: 16-Apr-2021 1:10 PM EDT
COVID-19: Scientists identify human genes that fight infection
Sanford Burnham Prebys Medical Discovery Institute

Scientists at Sanford Burnham Prebys have identified a set of human genes that fight SARS-CoV-2 infection, the virus that causes COVID-19. Knowing which genes help control viral infection can greatly assist researchers’ understanding of factors that affect disease severity and also suggest possible therapeutic options. The genes in question are related to interferons, the body’s frontline virus fighters.

Newswise: Study of More Than 3,000 Members of the US Marine Corps. Reveals Past COVID-19 Infection Does Not Fully Protect Young People Against Reinfection
Released: 16-Apr-2021 11:35 AM EDT
Study of More Than 3,000 Members of the US Marine Corps. Reveals Past COVID-19 Infection Does Not Fully Protect Young People Against Reinfection
Mount Sinai Health System

Although antibodies induced by SARS-CoV-2 infection are largely protective, they do not completely protect against reinfection in young people, as evidenced through a longitudinal, prospective study of more than 3,000 young, healthy members of the US Marines Corps conducted by researchers at the Icahn School of Medicine at Mount Sinai and the Naval Medical Research Center, published April 15 in The Lancet Respiratory Medicine.

Released: 15-Apr-2021 8:45 PM EDT
Beyond Boundaries: R Adams Cowley Shock Trauma Center Celebrates Heroes
University of Maryland Medical Center

More than 65 first responders and top trauma medicine professionals who saved the lives of two critically ill patients were honored tonight at the 31st annual R Adams Cowley Shock Trauma Celebration of Heroes. Funds raised by the virtual event will support the Center for Critical Care and Trauma Education.

Released: 15-Apr-2021 4:10 PM EDT
Penn Study Suggests Those Who Had COVID-19 May Only Need One Vaccine Dose
Perelman School of Medicine at the University of Pennsylvania

New findings from Penn suggest that people who have recovered from COVID-19 may only need a single mRNA vaccine dose. However, those who did not have COVID-19 did not have a full immune response until after a second vaccine dose, reinforcing the importance of completing the two recommended doses.


Showing results

110 of 5429

close
1.07045